Democratic Policy and Communications Chair David N. Cicilline (RI-01) introduced the Affordable Prescriptions for Patients Through Promoting Competition Act of 2019 today to increase competition in the prescription drug market by prohibiting pharmaceutical companies from engaging in harmful “product hopping” that increases corporate profits at the expense of consumers.
House Antitrust Subcommittee Chairman David N. Cicilline (RI-01) issued a statement in response to a report in the Wall Street Journal that e-commerce giant Amazon manipulated its online search system late last year in ways that could benefit its own in-house products.
Today, Reps. Jerrold Nadler (D-N.Y.), Chairman of the House Judiciary Committee; Doug Collins (R-Ga.), Ranking Member of the House Judiciary Committee; David Cicilline (D-R.I.), Chairman of the Subcommittee on Antitrust, Commercial and Administrative Law and Jim Sensenbrenner (R-Wis.), Ranking Member of the Subcommittee on Antitrust, Commercial and Administrative Law sent document requests as part of its bipartisan investigation into competition in digital markets.
Welcome to the on-line office for Congressman David Cicilline. Please visit the Contact Me page to contact David electronically or click on the office location nearest you for details.
Get updates on important issues sent
directly to your email address.
Washington, DC
2233 Rayburn HOB
Washington, DC 20515
Phone: (202) 225-4911
Fax: (202) 225-3290
Hours: Monday-Friday 9:00AM-6:00PM Eastern time
